CardiOCare's project logo

An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity

New review paper on clinical biomarkers as potential predictors of systemic therapy-induced cardiotoxicity in women with Breast Cancer

Jul 6, 2023

Our review entitled “New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review ” was published in Cancers journal. The aim of the systematic review is to provide an overview of the human studies, which explore novel insights into traditional biomarkers and/or novel biomarkers that can be used for the early detection and/or prediction of CTRCD in breast cancer patients undergoing cardiotoxic-cancer therapies.


CARDIOCARE in the ESC Spring Summit 2024

CARDIOCARE in the ESC Spring Summit 2024

CARDIOCARE was communicated in the ESC Spring Summit 2024 that took place on the 7th and the 8th of March 2024 at the European Heart House, in Nice, France. Read more: